My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 187

    1.

    Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.

    Van de Werf F, Nobuhara M, Collen D.

    Ann Intern Med. 1986 Mar;104(3):345-8.PMID: 3080936 [PubMed - indexed for MEDLINE]Related articles

    2.

    Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.

    Collen D, Van de Werf F.

    Am J Cardiol. 1987 Sep 1;60(7):431-4.PMID: 3115077 [PubMed - indexed for MEDLINE]Related articles

    3.

    Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.

    Flameng W, Vanhaecke J, Stump DC, Van de Werf F, Holmes W, Guenzler WA, Flohe L, Collen D.

    J Am Coll Cardiol. 1986 Jul;8(1):118-24.PMID: 3086416 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.

    Kirshenbaum JM, Bahr RD, Flaherty JT, Gurewich V, Levine HJ, Loscalzo J, Schumacher RR, Topol EJ, Wahr DW, Braunwald E.

    Am J Cardiol. 1991 Dec 15;68(17):1564-9.PMID: 1746455 [PubMed - indexed for MEDLINE]Related articles

    5.

    Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.

    Diefenbach C, Erbel R, Pop T, Mathey D, Schofer J, Hamm C, Ostermann H, Schmitz-Hübner U, Bleifeld W, Meyer J.

    Am J Cardiol. 1988 May 1;61(13):966-70. Review.PMID: 2452563 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clot-selective coronary thrombolysis with pro-urokinase.

    Loscalzo J, Wharton TP, Kirshenbaum JM, Levine HJ, Flaherty JT, Topol EJ, Ramaswamy K, Kosowsky BD, Salem DN, Ganz P, et al.

    Circulation. 1989 Apr;79(4):776-82.PMID: 2494004 [PubMed - indexed for MEDLINE]Related articles

    7.

    Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction.

    Kambara H, Kawai C, Kajiwara N, Niitani H, Sasayama S, Kanmatsuse K, Kodama K, Sato H, Nobuyoshi M, Nakashima M, et al.

    Circulation. 1988 Oct;78(4):899-905.PMID: 3139325 [PubMed - indexed for MEDLINE]Related articles

    8.

    Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.

    Van de Werf F, Ludbrook PA, Bergmann SR, Tiefenbrunn AJ, Fox KA, de Geest H, Verstraete M, Collen D, Sobel BE.

    N Engl J Med. 1984 Mar 8;310(10):609-13.PMID: 6537987 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Initial experiences with pro-urokinase in acute myocardial infarct]

    Schanzenbächer P, Huber J, Keller F, Kochsiek K.

    Z Kardiol. 1987 Sep;76(9):570-5. German. PMID: 3122430 [PubMed - indexed for MEDLINE]Related articles

    10.

    Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.

    Van de Werf F, Vanhaecke J, de Geest H, Verstraete M, Collen D.

    Circulation. 1986 Nov;74(5):1066-70.PMID: 2429783 [PubMed - indexed for MEDLINE]Related articles

    11.

    Coronary reperfusion studies with pro-urokinase in acute myocardial infarction: evidence for synergism of low dose urokinase.

    Kasper W, Hohnloser SH, Engler H, Meinertz T, Wilkens J, Roth E, Lang K, Limbourg P, Just H.

    J Am Coll Cardiol. 1990 Sep;16(3):733-8.PMID: 2117622 [PubMed - indexed for MEDLINE]Related articles

    12.

    Coronary thrombolysis with K1K2Pu, a chimeric tissue-type and urokinase-type plasminogen activator: a feasibility study in six patients with acute myocardial infarction.

    Van de Werf F, Lijnen HR, Collen D.

    Coron Artery Dis. 1993 Oct;4(10):929-33.PMID: 8269200 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.

    Bode C, Schoenermark S, Schuler G, Zimmermann R, Schwarz F, Kuebler W.

    Am J Cardiol. 1988 May 1;61(13):971-4.PMID: 2452564 [PubMed - indexed for MEDLINE]Related articles

    14.

    Coronary thrombolysis with clot-selective plasminogen activators.

    Collen D, Bounameaux H.

    Herz. 1986 Feb;11(1):9-15.PMID: 3082731 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravenous thrombolytic therapy with a combination of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator in acute myocardial infarction.

    Bode C, Schuler G, Nordt T, Schönermark S, Baumann H, Richardt G, Dietz R, Gurewich V, Kübler W.

    Circulation. 1990 Mar;81(3):907-13.PMID: 2106403 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

    Neuhaus KL, Tebbe U, Gottwik M, Weber MA, Feuerer W, Niederer W, Haerer W, Praetorius F, Grosser KD, Huhmann W, et al.

    J Am Coll Cardiol. 1988 Sep;12(3):581-7.PMID: 3042835 [PubMed - indexed for MEDLINE]Related articles

    17.

    Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.

    Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rüdiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G, et al.

    J Am Coll Cardiol. 1995 Aug;26(2):365-73.PMID: 7608436 [PubMed - indexed for MEDLINE]Related articles

    18.

    Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.

    Salvioni A, Perego GB, Marenzi G, Lauri G, Giraldi F, Grazi S, Guazzi MD.

    Eur Heart J. 1996 Feb;17(2):230-6.PMID: 8732376 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. PRIMI Trial Study Group.

    [No authors listed]

    Lancet. 1989 Apr 22;1(8643):863-8.PMID: 2564949 [PubMed - indexed for MEDLINE]Related articles

    20.

    Coronary thrombolysis for evolving myocardial infarction.

    Spann JF, Sherry S.

    Drugs. 1984 Nov;28(5):465-83. Review.PMID: 6391890 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity